Michael Varlotta, CCEP, HMCCPresident at MLVII Associates
Michael’s career in Bio Pharm spans for over 25 years with the last 15 in compliance, medical education, and operations as part of medical affairs and marketing. Currently Michael is President/CEO of MLVII Associates, a company helping Pharma address issues and concerns with compliance and FFS activities as well as KOL engagement. During his 22-year tenure at JnJ he led multiple compliance policy updates and operationalizing transparency for J&J. He harmonized policies and procedures for the pharma and device sectors of J&J including fee schedules, tiering of KOL’s, SOPs for travel policies and procedures for food and beverage. He led a cross pharma team focused on speaker programs, ad boards and conventions. He has also developed a streamline process and state of the art system for grant, advisory boards and speaker bureaus while increasing both internal and external customer satisfaction with the process. Michael always stays on top of the most recent positions and statements by regulating bodies and is proactive at making change. He is known to be independent minded, pioneering, passionate and inherently practical, looks for ways to drive change and efficiencies. Moves forward with a sense of confidence, commitment, compliance, and competence. Problems and processes are organized and simplified. Values guided, with a reputation for being ethical, responsible, and accountable while working hard to optimize opportunities.
Michael also has extensive experience in brand marketing and sales with direct responsibility for more than 3 launches and participated as a senior member on dozens of other launches. He is a Certified Compliance and Ethics Professional (CCEP) and has his Healthcare Meeting Compliance Certificate (HMCC).